Surgery Partners, Inc. (SGRY)
USD 23.08
(2.9%)
USD 23.08
(2.9%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 446.1 Million USD | 4.44% |
| 2022 | 460 Million USD | 11.52% |
| 2021 | 401 Million USD | 32.43% |
| 2020 | 277.8 Million USD | -0.87% |
| 2019 | 336.6 Million USD | 4.64% |
| 2018 | 144.67 Million USD | 29.19% |
| 2017 | 251.88 Million USD | 5.64% |
| 2016 | 245.22 Million USD | 148.25% |
| 2015 | 59.38 Million USD | -13.86% |
| 2014 | 65.86 Million USD | 37.14% |
| 2013 | 69.88 Million USD | 13.44% |
| 2012 | 72.49 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 138.9 Million USD | 9.02% |
| 2024 Q1 | 122.1 Million USD | -36.48% |
| 2023 Q2 | 126.7 Million USD | 19.42% |
| 2023 Q1 | 106.1 Million USD | -37.51% |
| 2023 FY | - USD | 4.44% |
| 2023 Q4 | 172.7 Million USD | 1351.26% |
| 2023 Q3 | 11.9 Million USD | -90.61% |
| 2022 Q3 | 118.6 Million USD | 4.22% |
| 2022 Q2 | 113.8 Million USD | 11.57% |
| 2022 Q4 | 169.8 Million USD | 43.17% |
| 2022 FY | - USD | 11.52% |
| 2022 Q1 | 102 Million USD | -33.25% |
| 2021 FY | - USD | 32.43% |
| 2021 Q1 | 94.4 Million USD | -26.13% |
| 2021 Q3 | 100.4 Million USD | -3.92% |
| 2021 Q4 | 152.8 Million USD | 52.19% |
| 2021 Q2 | 104.5 Million USD | 10.7% |
| 2020 Q3 | 82.2 Million USD | 8.3% |
| 2020 FY | - USD | -0.87% |
| 2020 Q1 | 55.5 Million USD | -49.59% |
| 2020 Q4 | 127.8 Million USD | 55.47% |
| 2020 Q2 | 75.9 Million USD | 36.76% |
| 2019 Q1 | 68.6 Million USD | -37.85% |
| 2019 Q4 | 110.1 Million USD | 35.26% |
| 2019 Q3 | 81.4 Million USD | -3.44% |
| 2019 Q2 | 84.3 Million USD | 22.89% |
| 2019 FY | - USD | 4.64% |
| 2018 Q4 | 110.38 Million USD | 35.14% |
| 2018 Q1 | 61.99 Million USD | -48.08% |
| 2018 Q2 | 75.2 Million USD | 21.32% |
| 2018 Q3 | 81.67 Million USD | 8.6% |
| 2018 FY | - USD | 29.19% |
| 2017 Q3 | -4.12 Million USD | -108.47% |
| 2017 FY | - USD | 5.64% |
| 2017 Q4 | 119.39 Million USD | 2996.63% |
| 2017 Q2 | 48.67 Million USD | -10.47% |
| 2017 Q1 | 54.36 Million USD | -19.95% |
| 2016 FY | - USD | 148.25% |
| 2016 Q3 | 54.85 Million USD | -13.34% |
| 2016 Q4 | 67.9 Million USD | 23.79% |
| 2016 Q2 | 63.3 Million USD | 14.91% |
| 2016 Q1 | 55.09 Million USD | 184.25% |
| 2015 Q2 | 55.2 Million USD | 6.07% |
| 2015 Q1 | 52.04 Million USD | 10.22% |
| 2015 FY | - USD | -13.86% |
| 2015 Q3 | 55.29 Million USD | 0.17% |
| 2015 Q4 | -65.39 Million USD | -218.26% |
| 2014 Q3 | 22.8 Million USD | -2.88% |
| 2014 Q1 | 19.27 Million USD | 0.0% |
| 2014 Q2 | 23.48 Million USD | 21.86% |
| 2014 FY | - USD | 37.14% |
| 2014 Q4 | 47.21 Million USD | 107.04% |
| 2013 FY | - USD | 13.44% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | -135.889% |
| Addus HomeCare Corporation | 106.55 Million USD | -318.645% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | -1475.657% |
| Amedisys, Inc. | 216.91 Million USD | -105.658% |
| Astrana Health, Inc. | 123.68 Million USD | -260.666% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | -905.908% |
| IMAC Holdings, Inc. | -5.94 Million USD | 7601.52% |
| biote Corp. | 9.23 Million USD | -4731.059% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 4382.304% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | -244.918% |
| COMPASS Pathways plc | -123.8 Million USD | 460.333% |
| DocGo Inc. | 32.72 Million USD | -1263.17% |
| The Ensign Group, Inc. | 353.23 Million USD | -26.29% |
| Healthcare Services Group, Inc. | 75.21 Million USD | -493.123% |
| InnovAge Holding Corp. | 1.15 Million USD | -38556.846% |
| The Joint Corp. | 9.14 Million USD | -4779.826% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 525.157% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 2967.95% |
| ModivCare Inc. | -26.75 Million USD | 1767.664% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -115979.676% |
| Option Care Health, Inc. | 376.79 Million USD | -18.393% |
| P3 Health Partners Inc. | -81.07 Million USD | 650.258% |
| P3 Health Partners Inc. | -81.07 Million USD | 650.258% |
| The Pennant Group, Inc. | 30.36 Million USD | -1368.932% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 15830.534% |
| Talkspace, Inc. | -22.01 Million USD | 2126.53% |
| Talkspace, Inc. | -22.01 Million USD | 2126.53% |
| The Oncology Institute, Inc. | -70.45 Million USD | 733.179% |
| The Oncology Institute, Inc. | -70.45 Million USD | 733.179% |